Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
| Autor: | Boeck, S., Hoehler, T., Seipelt, G., Mahlberg, R., Wein, A., Hochhaus, A., Boeck, H.-P., Schmid, B., Kettner, E., Stauch, M., Lordick, F., Ko, Y., Geissler, M., Schoppmeyer, K., Kojouharoff, G., Golf, A., Neugebauer, S., Heinemann, V. * |
|---|---|
| Zdroj: | In Annals of Oncology February 2008 19(2):340-347 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|